J

Japan Tissue Engineering Co Ltd
TSE:7774

Watchlist Manager
Japan Tissue Engineering Co Ltd
TSE:7774
Watchlist
Price: 435 JPY -3.33% Market Closed
Market Cap: 17.7B JPY
Have any thoughts about
Japan Tissue Engineering Co Ltd?
Write Note

Japan Tissue Engineering Co Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Japan Tissue Engineering Co Ltd
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
J
Japan Tissue Engineering Co Ltd
TSE:7774
Depreciation & Amortization
ÂĄ145.7m
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
5%
GNI Group Ltd
TSE:2160
Depreciation & Amortization
ÂĄ846.8m
CAGR 3-Years
29%
CAGR 5-Years
32%
CAGR 10-Years
36%
PeptiDream Inc
TSE:4587
Depreciation & Amortization
ÂĄ2.3B
CAGR 3-Years
56%
CAGR 5-Years
35%
CAGR 10-Years
40%
Takara Bio Inc
TSE:4974
Depreciation & Amortization
ÂĄ4.7B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
13%
Pharma Foods International Co Ltd
TSE:2929
Depreciation & Amortization
ÂĄ907m
CAGR 3-Years
71%
CAGR 5-Years
58%
CAGR 10-Years
43%
C
Cuorips Inc
TSE:4894
Depreciation & Amortization
ÂĄ70.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Japan Tissue Engineering Co Ltd
Glance View

Market Cap
17.7B JPY
Industry
Biotechnology

Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. The company is headquartered in Gamagori-Shi, Aichi-Ken and currently employs 200 full-time employees. The company went IPO on 2007-12-21. The firm operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The Research and Development Supports segment is engaged in the development, manufacture and sale of laboratory human cultured tissues based on tissue engineering technology and manufacturing know-how for cosmetic and pharmaceutical product manufacturers.

Intrinsic Value
376.39 JPY
Overvaluation 13%
Intrinsic Value
Price
J

See Also

What is Japan Tissue Engineering Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
145.7m JPY

Based on the financial report for Sep 30, 2024, Japan Tissue Engineering Co Ltd's Depreciation & Amortization amounts to 145.7m JPY.

What is Japan Tissue Engineering Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
5%

Over the last year, the Depreciation & Amortization growth was 9%. The average annual Depreciation & Amortization growth rates for Japan Tissue Engineering Co Ltd have been 5% over the past three years , 3% over the past five years , and 5% over the past ten years .

Back to Top